drugset
Drugs / Dulera
last change Jul 2017 re-read 3 minutes ago

Dulera

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved US (FDA) DULERA — 2010-06-22 fda.gov ↗

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 4 NCT02045875 Background Mar 2014 → Jul 2017 asthma Asthma Management Systems Completed No outcome recorded

Press releases naming this drug 2 releases

DateIssuerRelease
2017-05-22 Merck Sharp & Dohme LLC Merck Announces Top-Line Results from the Long Term LABA Safety Study of DULERA (mometasone furoate and formoterol fumarate dihydrate) Inhalation Aerosol merck.com ↗
2011-10-24 Merck Sharp & Dohme LLC Merck Announces Presentation of Phase III Investigational Studies Evaluating DULERA® (mometasone furoate and formoterol fumarate dihydrate) Inhalation Aerosol in Chronic Obstructive Pulmonary Disease (COPD) merck.com ↗

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Dulera ClinicalTrials.gov intervention name — accepted as the source's own label NCT02045875 ↗